Protocol # NU 98H2: Phase I/II Study of Mesna, Ifosfamide, Teniposide and Weekly Taxol (MITTen) in Relapsed Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date8/10/991/1/11

Funding

  • Bristol-Myers Squibb Company (NU 98H2)